Skip to main content
ViGenCell Inc. logo

ViGenCell Inc. — Investor Relations & Filings

Ticker · 308080 ISIN · KR7308080001 KO Professional, scientific and technical activities
Open in API
Filings indexed 134 across all filing types
Latest filing 2022-03-07 Proxy Solicitation & In…
Country KR South Korea
Listing KO 308080

About ViGenCell Inc.

https://www.vigencell.com/en/

ViGenCell Inc. is a biotechnology company specializing in the development of immune cell therapies. The company focuses on creating treatments for cancer and other incurable diseases by enhancing a patient's own immunity. Its core technologies include the ViTier platform, which utilizes antigen-specific killer T cells to target and remove cancer cells, and the ViRanger platform, a T-cell gene therapy technology. These proprietary platforms form the basis of its pipeline of novel immune cell therapeutics designed to prolong life and improve patient outcomes.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Vigencell Co., Ltd. It includes the meeting date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and management's reference materials regarding business operations and board activities. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-07 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting/presentation. It provides details such as the date, time, location (online), target audience (analysts and institutional investors), and the purpose of the event. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure announcement.
2022-02-25 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company 'Vigencell'. It details the date, location, and specific agenda items for the upcoming meeting, including the approval of financial statements, appointment of directors, and appointment of audit committee members. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and request their participation/votes, which aligns with the PSI (Proxy Solicitation & Information Statement) category.
2022-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Vigencell) announcing a significant change (over 30%) in its financial structure (revenue or profit/loss) compared to the previous fiscal year. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. It provides specific financial data (operating profit, net income, assets, liabilities) and explains the reasons for the variance. It is not a full annual report, but rather a specific regulatory disclosure of financial results, which falls under the 'Earnings Release' category as it provides the initial announcement of financial performance metrics. FY 2021
2022-02-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure for insiders (executives/major shareholders) to report their shareholdings and changes therein. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider share transactions and ownership reporting.
2022-01-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. This is a standard regulatory filing used to disclose insider shareholdings and transactions by company directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions and ownership status by company directors and executives.
2022-01-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.